VANDA PHARMACEUTICALS INC. (VNDA) Total liabilities 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) total liabilities at each fiscal year-end, per SEC filings.
$161.8MFY2025 · since FY2016: $79.0M → $161.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $161.8M | +37.5% |
| FY2024 | $117.7M | +13.6% |
| FY2023 | $103.5M | -3.3% |
| FY2022 | $107.0M | +20.5% |
| FY2021 | $88.9M | +10.8% |
| FY2020 | $80.2M | +10.1% |
| FY2019 | $72.8M | +28.4% |
| FY2018 | $56.7M | -23.4% |
| FY2017 | $74.0M | -6.3% |
| FY2016 | $79.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice